505 related articles for article (PubMed ID: 24815298)
1. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study.
Sisson G; Ayis S; Sherwood RA; Bjarnason I
Aliment Pharmacol Ther; 2014 Jul; 40(1):51-62. PubMed ID: 24815298
[TBL] [Abstract][Full Text] [Related]
2. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
[TBL] [Abstract][Full Text] [Related]
3. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live
Srivastava S; Basak U; Naghibi M; Vijayakumar V; Parihar R; Patel J; Jadon PS; Pandit A; Dargad RR; Khanna S; Kumar S; Day R
Gut Microbes; 2024; 16(1):2338322. PubMed ID: 38630015
[TBL] [Abstract][Full Text] [Related]
5. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial.
Francavilla R; Piccolo M; Francavilla A; Polimeno L; Semeraro F; Cristofori F; Castellaneta S; Barone M; Indrio F; Gobbetti M; De Angelis M
J Clin Gastroenterol; 2019 Mar; 53(3):e117-e125. PubMed ID: 29688915
[TBL] [Abstract][Full Text] [Related]
8. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
9. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.
Lorenzo-Zúñiga V; Llop E; Suárez C; Alvarez B; Abreu L; Espadaler J; Serra J
World J Gastroenterol; 2014 Jul; 20(26):8709-16. PubMed ID: 25024629
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
Whorwell PJ; Altringer L; Morel J; Bond Y; Charbonneau D; O'Mahony L; Kiely B; Shanahan F; Quigley EM
Am J Gastroenterol; 2006 Jul; 101(7):1581-90. PubMed ID: 16863564
[TBL] [Abstract][Full Text] [Related]
11. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
Lyra A; Hillilä M; Huttunen T; Männikkö S; Taalikka M; Tennilä J; Tarpila A; Lahtinen S; Ouwehand AC; Veijola L
World J Gastroenterol; 2016 Dec; 22(48):10631-10642. PubMed ID: 28082816
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Probiotic Escherichia coli Nissle 1917 in Patients with Irritable Bowel Syndrome: a Double Blind Placebo-controlled Randomized Trial.
Faghihi AH; Agah S; Masoudi M; Ghafoori SM; Eshraghi A
Acta Med Indones; 2015 Jul; 47(3):201-8. PubMed ID: 26586385
[TBL] [Abstract][Full Text] [Related]
13. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
14. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Guglielmetti S; Mora D; Gschwender M; Popp K
Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
[TBL] [Abstract][Full Text] [Related]
15. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease.
Bjarnason I; Sission G; Hayee B
Inflammopharmacology; 2019 Jun; 27(3):465-473. PubMed ID: 31054010
[TBL] [Abstract][Full Text] [Related]
16. The Effectiveness of Synbiotic Preparation Containing
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA
Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
[TBL] [Abstract][Full Text] [Related]
18. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
Bittner AC; Croffut RM; Stranahan MC
Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
[TBL] [Abstract][Full Text] [Related]
19. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
Konstantis G; Efstathiou S; Pourzitaki C; Kitsikidou E; Germanidis G; Chourdakis M
Clin Nutr; 2023 May; 42(5):800-809. PubMed ID: 37031468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
